109 related articles for article (PubMed ID: 1961009)
1. Effects of amsacrine in combination with other anticancer agents in human acute lymphoblastic leukemia cells in culture.
Kano Y; Sakamoto S; Kasahara T; Akutsu M; Inoue Y; Miura Y
Leuk Res; 1991; 15(11):1059-66. PubMed ID: 1961009
[TBL] [Abstract][Full Text] [Related]
2. Effects of mitoxantrone in combination with other anticancer agents on a human leukemia cell line.
Kano Y; Suzuki K; Akutsu M; Suda K
Leukemia; 1992 May; 6(5):440-5. PubMed ID: 1593909
[TBL] [Abstract][Full Text] [Related]
3. The effects of ICRF-154 in combination with other anticancer agents in vitro.
Kano Y; Narita T; Suzuki K; Akutsu M; Suda K; Sakamoto S; Miura Y
Br J Cancer; 1992 Aug; 66(2):281-6. PubMed ID: 1503899
[TBL] [Abstract][Full Text] [Related]
4. Effects of CPT-11 in combination with other anti-cancer agents in culture.
Kano Y; Suzuki K; Akutsu M; Suda K; Inoue Y; Yoshida M; Sakamoto S; Miura Y
Int J Cancer; 1992 Feb; 50(4):604-10. PubMed ID: 1537625
[TBL] [Abstract][Full Text] [Related]
5. Effects of carboplatin in combination with other anticancer agents on human leukemia cell lines.
Kano Y; Akutsu M; Suzuki K; Yoshida M
Leuk Res; 1993 Feb; 17(2):113-9. PubMed ID: 8429687
[TBL] [Abstract][Full Text] [Related]
6. [Effects of SN-38 in combination with other anticancer agents against Dauji cells].
Akutsu M; Suzuki K; Tsunoda S; Kano Y; Miura Y
Gan To Kagaku Ryoho; 1994 Aug; 21(10):1607-11. PubMed ID: 8060135
[TBL] [Abstract][Full Text] [Related]
7. Effects of 4-hydroperoxy ifosfamide in combination with other anticancer agents on human cancer cell lines.
Yazawa Y; Takagi T; Asakura S; Suzuki K; Kano Y
J Orthop Sci; 1999; 4(3):231-7. PubMed ID: 10370165
[TBL] [Abstract][Full Text] [Related]
8. Effects of 13-hydroxy SM5887 in combination with other anticancer agents on human tumor cell lines.
Takagi T; Yazawa Y; Suzuki K; Yamauchi Y; Kano Y
Invest New Drugs; 1996; 14(4):357-63. PubMed ID: 9157070
[TBL] [Abstract][Full Text] [Related]
9. Schedule-dependent synergism and antagonism between methotrexate and 6-mercaptopurine in a human acute lymphoblastic cell line.
Kano Y; Akutsu M; Kasahara T; Sakamoto S
Eur J Cancer; 1991; 27(9):1141-5. PubMed ID: 1835625
[TBL] [Abstract][Full Text] [Related]
10. Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture.
Kano Y; Ohnuma T; Okano T; Holland JF
Cancer Res; 1988 Jan; 48(2):351-6. PubMed ID: 3422052
[TBL] [Abstract][Full Text] [Related]
11. The cytotoxic effects of gemtuzumab ozogamicin (mylotarg) in combination with conventional antileukemic agents by isobologram analysis in vitro.
Tanaka M; Kano Y; Akutsu M; Tsunoda S; Izumi T; Yazawa Y; Miyawaki S; Mano H; Furukawa Y
Anticancer Res; 2009 Nov; 29(11):4589-96. PubMed ID: 20032408
[TBL] [Abstract][Full Text] [Related]
12. [Effects of carboplatin combination with etoposide against leukemia/lymphoma cell lines].
Akutsu M; Suzuki K; Tsunoda S; Kano Y
Gan To Kagaku Ryoho; 1996 Feb; 23(3):297-302. PubMed ID: 8712822
[TBL] [Abstract][Full Text] [Related]
13. Intracellular cytosine arabinoside accumulation and cytosine arabinoside triphosphate formation in leukemic blast cells is inhibited by etoposide and teniposide.
Ehninger G; Proksch B; Wanner T; Schuler U; Busch FW; Schmidt H; Schleyer E; Jaschonek K; Hiddemann W
Leukemia; 1992 Jun; 6(6):582-7. PubMed ID: 1602795
[TBL] [Abstract][Full Text] [Related]
14. Effect of CPT-11 in combination with other anticancer agents in lung cancer cells.
Pei XH; Nakanishi Y; Takayama K; Bai F; Kawasaki M; Tsuruta N; Mizuno K; Hara N
Anticancer Drugs; 1997 Mar; 8(3):231-7. PubMed ID: 9095327
[TBL] [Abstract][Full Text] [Related]
15. Intermediate-risk childhood acute lymphoblastic leukemias: amsacrine + cytosine arabinoside versus intermediate-dose methotrexate for consolidation, and 6-mercaptopurine + methotrexate + vincristine versus monthly pulses for maintenance.
Schaison G; Leverger G; Bancillon A; Marty M; Olive D; Cornu G; Griscelli C; Lemerle S; Harousseau JL; Bonnet M
Haematol Blood Transfus; 1987; 30():461-5. PubMed ID: 3305213
[No Abstract] [Full Text] [Related]
16. Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
Tallman MS; Appelbaum FR; Amos D; Goldberg RS; Livingston RB; Mortimer J; Weiden PL; Thomas ED
J Clin Oncol; 1987 Jun; 5(6):918-26. PubMed ID: 3585446
[TBL] [Abstract][Full Text] [Related]
17. Interactions between cladribine (2-chlorodeoxyadenosine) and standard antileukemic drugs in primary cultures of human tumor cells from patients with acute myelocytic leukemia.
Kristensen J; Nygren P; Liliemark J; Fridborg H; Killander A; Simonsson B; Oberg G; Larsson R
Leukemia; 1994 Oct; 8(10):1712-7. PubMed ID: 7934168
[TBL] [Abstract][Full Text] [Related]
18. Effects of harringtonine in combination with acivicin, adriamycin, L-asparaginase, cytosine arabinoside, dexamethasone, fluorouracil or methotrexate on human acute myelogenous leukemia cell line KG-1.
Okano T; Ohnuma T; Holland JF; Koeffler HP; Jui H
Invest New Drugs; 1983; 1(2):145-50. PubMed ID: 6590529
[TBL] [Abstract][Full Text] [Related]
19. Cytosine arabinoside in experimental combination therapy.
Edelstein M; Valeriote F
Semin Oncol; 1985 Jun; 12(2 Suppl 3):75-83. PubMed ID: 3892705
[No Abstract] [Full Text] [Related]
20. Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines.
Kano Y; Akutsu M; Tsunoda S; Izumi T; Kobayashi H; Mano H; Furukawa Y
Invest New Drugs; 2007 Feb; 25(1):31-40. PubMed ID: 16865529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
